306 related articles for article (PubMed ID: 25649348)
1. A multicentre study of meticillin-resistant Staphylococcus aureus in acute bacterial skin and skin-structure infections in China: susceptibility to ceftaroline and molecular epidemiology.
Zhang H; Xiao M; Kong F; O'Sullivan MV; Mao LL; Zhao HR; Zhao Y; Wang H; Xu YC
Int J Antimicrob Agents; 2015 Apr; 45(4):347-50. PubMed ID: 25649348
[TBL] [Abstract][Full Text] [Related]
2. National surveillance of methicillin-resistant Staphylococcus aureus in China highlights a still-evolving epidemiology with 15 novel emerging multilocus sequence types.
Xiao M; Wang H; Zhao Y; Mao LL; Brown M; Yu YS; O'Sullivan MV; Kong F; Xu YC
J Clin Microbiol; 2013 Nov; 51(11):3638-44. PubMed ID: 23985906
[TBL] [Abstract][Full Text] [Related]
3. [Infectivity-resistotype-genotype clustering of methicillin-resistant Staphylococcus aureus strains in the Central Blacksea Region of Turkey].
Kırca Yılmaz S; Acuner IC; Strommenger B; Bek Y; Witte W
Mikrobiyol Bul; 2014 Jan; 48(1):14-27. PubMed ID: 24506712
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial activity of ceftaroline and comparator agents tested against bacterial isolates causing skin and soft tissue infections and community-acquired respiratory tract infections isolated from the Asia-Pacific region and South Africa (2010).
Sader HS; Flamm RK; Jones RN
Diagn Microbiol Infect Dis; 2013 May; 76(1):61-8. PubMed ID: 23535208
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of ceftaroline and comparator antimicrobials against European and Middle East isolates from complicated skin and skin-structure infections collected in 2008-2009.
Morrissey I; Leakey A; Northwood JB
Int J Antimicrob Agents; 2012 Sep; 40(3):227-34. PubMed ID: 22796201
[TBL] [Abstract][Full Text] [Related]
6. Characterization of methicillin-resistant Staphylococcus aureus displaying increased MICs of ceftaroline.
Mendes RE; Tsakris A; Sader HS; Jones RN; Biek D; McGhee P; Appelbaum PC; Kosowska-Shick K
J Antimicrob Chemother; 2012 Jun; 67(6):1321-4. PubMed ID: 22398650
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and molecular characteristics of community-associated methicillin-resistant and methicillin-susceptible Staphylococcus aureus from skin/soft tissue infections in a children's hospital in Beijing, China.
Wu D; Wang Q; Yang Y; Geng W; Wang Q; Yu S; Yao K; Yuan L; Shen X
Diagn Microbiol Infect Dis; 2010 May; 67(1):1-8. PubMed ID: 20227225
[TBL] [Abstract][Full Text] [Related]
8. A 12-year survey of methicillin-resistant Staphylococcus aureus infections in Greece: ST80-IV epidemic?
Drougka E; Foka A; Liakopoulos A; Doudoulakakis A; Jelastopulu E; Chini V; Spiliopoulou A; Levidiotou S; Panagea T; Vogiatzi A; Lebessi E; Petinaki E; Spiliopoulou I
Clin Microbiol Infect; 2014 Nov; 20(11):O796-803. PubMed ID: 24750462
[TBL] [Abstract][Full Text] [Related]
9. Molecular characteristics of community-acquired methicillin-resistant Staphylococcus aureus strains isolated from outpatients with skin and soft tissue infections in Wuhan, China.
Liu X; Liang J; Jiang Y; Wang B; Yuan H; Zhang L; Zhou Y; Xu H; Zhou W
Pathog Dis; 2016 Jun; 74(4):ftw026. PubMed ID: 27060098
[TBL] [Abstract][Full Text] [Related]
10. Ceftaroline activity against bacterial organisms isolated from acute bacterial skin and skin structure infections in United States medical centers (2009-2011).
Pfaller MA; Flamm RK; Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2014 Apr; 78(4):422-8. PubMed ID: 24445158
[TBL] [Abstract][Full Text] [Related]
11. Clinical isolates of Staphylococcus aureus from the Arkhangelsk region, Russia: antimicrobial susceptibility, molecular epidemiology, and distribution of Panton-Valentine leukocidin genes.
Vorobieva V; Bazhukova T; Hanssen AM; Caugant DA; Semenova N; Haldorsen BC; Simonsen GS; Sundsfjord A
APMIS; 2008 Oct; 116(10):877-87. PubMed ID: 19132981
[TBL] [Abstract][Full Text] [Related]
12. Clinical and molecular characteristics of nosocomial meticillin-resistant Staphylococcus aureus skin and soft tissue isolates from three Indian hospitals.
Gadepalli R; Dhawan B; Kapil A; Sreenivas V; Jais M; Gaind R; Chaudhry R; Samantaray JC; Udo EE
J Hosp Infect; 2009 Nov; 73(3):253-63. PubMed ID: 19782432
[TBL] [Abstract][Full Text] [Related]
13. Emergence of SCCmec type III with variable antimicrobial resistance profiles and spa types among methicillin-resistant Staphylococcus aureus isolated from healthcare- and community-acquired infections in the west of Iran.
Mohammadi S; Sekawi Z; Monjezi A; Maleki MH; Soroush S; Sadeghifard N; Pakzad I; Azizi-Jalilian F; Emaneini M; Asadollahi K; Pourahmad F; Zarrilli R; Taherikalani M
Int J Infect Dis; 2014 Aug; 25():152-8. PubMed ID: 24909489
[TBL] [Abstract][Full Text] [Related]
14. In Vitro Activity of Ceftaroline against Staphylococcus aureus Isolated in 2012 from Asia-Pacific Countries as Part of the AWARE Surveillance Program.
Biedenbach DJ; Alm RA; Lahiri SD; Reiszner E; Hoban DJ; Sahm DF; Bouchillon SK; Ambler JE
Antimicrob Agents Chemother; 2016 Jan; 60(1):343-7. PubMed ID: 26503659
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial activity of ceftaroline against methicillin-resistant Staphylococcus aureus (MRSA) isolates collected in 2013-2014 at the Geneva University Hospitals.
Andrey DO; François P; Manzano C; Bonetti EJ; Harbarth S; Schrenzel J; Kelley WL; Renzoni A
Eur J Clin Microbiol Infect Dis; 2017 Feb; 36(2):343-350. PubMed ID: 27744604
[TBL] [Abstract][Full Text] [Related]
16. Methicillin-resistant Staphylococcus aureus in Rio de Janeiro hospitals: dissemination of the USA400/ST1 and USA800/ST5 SCCmec type IV and USA100/ST5 SCCmec type II lineages in a public institution and polyclonal presence in a private one.
Caboclo RM; Cavalcante FS; Iorio NL; Schuenck RP; Olendzki AN; Felix MJ; Chamon RC; dos Santos KR
Am J Infect Control; 2013 Mar; 41(3):e21-6. PubMed ID: 23261682
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial susceptibility and molecular characteristics of methicillin-resistant Staphylococcus aureus in a Japanese secondary care facility.
Kimura Y; Morinaga Y; Akamatsu N; Matsuda J; Yamaryo T; Kawakami K; Matsuo H; Kosai K; Uno N; Hasegawa H; Yanagihara K
J Infect Chemother; 2016 Jan; 22(1):14-8. PubMed ID: 26617349
[TBL] [Abstract][Full Text] [Related]
18. Genotypic Characterization of Methicillin-Resistant Staphylococcus aureus Recovered at Baseline from Phase 3 Pneumonia Clinical Trials for Ceftobiprole.
Mendes RE; Deshpande LM; Costello AJ; Farrell DJ; Jones RN; Flamm RK
Microb Drug Resist; 2016 Jan; 22(1):53-8. PubMed ID: 26230870
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of spa types associated with the clonal lineage CC398 among tetracycline-resistant methicillin-resistant Staphylococcus aureus strains in a Spanish hospital.
Lozano C; Rezusta A; Gómez P; Gómez-Sanz E; Báez N; Martin-Saco G; Zarazaga M; Torres C
J Antimicrob Chemother; 2012 Feb; 67(2):330-4. PubMed ID: 22127589
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial Activity of Ceftaroline Tested against Staphylococcus aureus from Surgical Skin and Skin Structure Infections in US Medical Centers.
Sader HS; Farrell DJ; Flamm RK; Jones RN
Surg Infect (Larchmt); 2016 Aug; 17(4):443-7. PubMed ID: 26990170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
